William R. Jacobs Jr., Ph.D.

Microbiology & Immunology

Phone718-678-1075
Emailwilliam.jacobs@einsteinmed.org
Websitehttp://www.einstein.yu.edu/faculty/6703/william-jacobs-jr/

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where William R. Jacobs Jr. is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

20 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

3 Active
15 Finished

Generation of a Complete Set of Precise Null Bar-Coded Deletion Mutants of Mycobacterium tuberculosis
Jacobs Jr., W. R.
National Institute of Allergy and Infectious Diseases
9/14/17 → 8/31/21
Project: Research project
Attenuated HSV Vaccines That Induce Protective Mucosal Antibodies
Herold, B. & Jacobs Jr., W. R.
National Institute of Allergy and Infectious Diseases
3/1/16 → 2/28/21
Project: Research project
MOLECULAR GENETIC ANALYSIS OF MYCOBACTERIUM TUBERCULOSIS
Jacobs Jr., W. R.
National Institute of Allergy and Infectious Diseases
12/31/89 → 8/31/21
Project: Research project
Shortening Tuberculosis Chemotherapies using N-acetylcysteine
Jacobs Jr., W. R.
National Institute of Allergy and Infectious Diseases
6/15/18 → 5/31/20
Project: Research project
Reporter Phages for Diagnosis of Drug-Resistant TB in HIV High-Burden Populations
Jacobs Jr., W. R. & Rose, S. A.
National Institute of Allergy and Infectious Diseases
8/15/13 → 3/16/15
Project: Research project

33197 Citations
100 h-Index
373 Article
15 Review article
10 Comment/debate
9 Letter
More

3-(Phenethylamino)demethyl(oxy)aaptamine as an anti-dormant mycobacterial substance: Isolation, evaluation and total synthesis
Sumii, Y., Kotoku, N., Han, C., Kamiya, K., Setiawan, A., Vilchèze, C., Jacobs, W. R. & Arai, M., May 28 2020, In: Tetrahedron Letters. 61, 22, 151924.
Research output: Contribution to journal › Article › peer-review
A Single-Cycle Glycoprotein D Deletion Viral Vaccine Candidate, ΔgD-2, Elicits Polyfunctional Antibodies That Protect against Ocular Herpes Simplex Virus
Ramsey, N. L. M., Visciano, M., Hunte, R., Loh, L. N., Burn Aschner, C., Jacobs, W. R. & Herold, B. C., Jun 16 2020, In: Journal of virology. 94, 13
Research output: Contribution to journal › Article › peer-review
2 Scopus citations
BCG-Prime and boost with Esx-5 secretion system deletion mutant leads to better protection against clinical strains of Mycobacterium tuberculosis
Tiwari, S., Dutt, T. S., Chen, B., Chen, M., Kim, J., Dai, A. Z., Lukose, R., Shanley, C., Fox, A., Karger, B. R., Porcelli, S. A., Chan, J., Podell, B. K., Obregon-Henao, A., Orme, I. M., Jacobs, W. R. & Henao-Tamayo, M., Oct 21 2020, In: Vaccine. 38, 45, p. 7156-7165 10 p.
Research output: Contribution to journal › Article › peer-review
Characterization of large deletion mutants of mycobacterium tuberculosis selected for isoniazid resistance
Vilchèze, C., Saranathan, R., Weinrick, B. & Jacobs, W. R., Sep 2020, In: Antimicrobial agents and chemotherapy. 64, 9, e00792-20.
Research output: Contribution to journal › Article › peer-review
Drivers and sites of diversity in the DNA adenine methylomes of 93 mycobacterium tuberculosis complex clinical isolates
Modlin, S. J., Conkle-Gutierrez, D., Kim, C., Mitchell, S. N., Morrissey, C., Weinrick, B. C., Jacobs, W. R., Ramirez-Busby, S. M., Hoffner, S. E. & Valafar, F., Oct 2020, In: eLife. 9, p. 1-33 33 p., e58542.
Research output: Contribution to journal › Article › peer-review

Open Access